XML 56 R43.htm IDEA: XBRL DOCUMENT
v3.24.2

Revenue (Disaggregation of Revenue by Geographical Region) (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 28, 2024 | Jun. 30, 2023 | Jun. 28, 2024 | Jun. 30, 2023
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | $ 5,743 | $ 5,912 | $ 11,539 | $ 11,861
Recurring revenue |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 4,689 | 4,596 | 9,484 | 9,258
Nonrecurring revenue |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 1,054 | 1,316 | 2,055 | 2,603
North America |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 2,434 | 2,350 | 5,066 | 4,800
Western Europe |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 1,321 | 1,424 | 2,645 | 2,855
Other developed markets |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 292 | 296 | 595 | 620
High-growth markets |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 1,696 | 1,842 | 3,233 | 3,586
Operating segments | Biotechnology |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 1,713 | 1,885 | 3,237 | 3,749
Operating segments | Biotechnology | Recurring revenue |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 1,478 | 1,534 | 2,787 | 3,045
Operating segments | Biotechnology | Nonrecurring revenue |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 235 | 351 | 450 | 704
Operating segments | Biotechnology | North America |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 607 | 611 | 1,121 | 1,229
Operating segments | Biotechnology | Western Europe |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 567 | 684 | 1,113 | 1,331
Operating segments | Biotechnology | Other developed markets |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 81 | 72 | 160 | 151
Operating segments | Biotechnology | High-growth markets |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 458 | 518 | 843 | 1,038
Operating segments | Life Sciences |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 1,770 | 1,796 | 3,515 | 3,505
Operating segments | Life Sciences | Recurring revenue |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 1,208 | 1,104 | 2,400 | 2,143
Operating segments | Life Sciences | Nonrecurring revenue |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 562 | 692 | 1,115 | 1,362
Operating segments | Life Sciences | North America |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 785 | 757 | 1,566 | 1,465
Operating segments | Life Sciences | Western Europe |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 374 | 375 | 746 | 739
Operating segments | Life Sciences | Other developed markets |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 116 | 124 | 241 | 252
Operating segments | Life Sciences | High-growth markets |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 495 | 540 | 962 | 1,049
Operating segments | Diagnostics |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 2,260 | 2,231 | 4,787 | 4,607
Operating segments | Diagnostics | Recurring revenue |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 2,003 | 1,958 | 4,297 | 4,070
Operating segments | Diagnostics | Nonrecurring revenue |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 257 | 273 | 490 | 537
Operating segments | Diagnostics | North America |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 1,042 | 982 | 2,379 | 2,106
Operating segments | Diagnostics | Western Europe |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 380 | 365 | 786 | 785
Operating segments | Diagnostics | Other developed markets |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | 95 | 100 | 194 | 217
Operating segments | Diagnostics | High-growth markets |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Revenue | $ 743 | $ 784 | $ 1,428 | $ 1,499

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=dhr_RevenuefromContractwithCustomerMeasurementRecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=dhr_RevenuefromContractwithCustomerMeasurementNonrecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_NorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_WesternEuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_OtherdevelopedmarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_HighgrowthmarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_BiotechnologySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_LifeSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_DiagnosticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |